Close

South Korea And US FDA Join Forces For Medical AI Innovation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

CMS in US Launches WISeR Model to Enhance Original Medicare

The Centers for Medicare & Medicaid Services (CMS) is...

England GP IT Market Witnesses Shake-Up Unseen in 25 Years

England’s National Health Service, which is popularly known as...

Label Expansion In Alzheimers Gives GE HealthCare An Edge

The US Food and Drug Administration (FDA) has gone...

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

The president of the Republic of South Korea, Yoon Suk Yeol, and the minister of food and safety of the country, Oh Yu-Kyoung, recently went on to meet the commissioner of the US Food and Drug Administration, Dr. Robert M. Califf, so as to discuss the collaboration between the two organisations pertaining to digital health and also inked a memorandum of cooperation in order to strengthen the medical products cooperation by way of using artificial intelligence.

Memorandum of Cooperation being inked happens to be part of strengthening the collaboration between the US and Korea high tech alliance and supports the emerging as well as core technology cooperation that is agreed between the two leaders.

The meeting was also promoted as a follow-up to the meeting between Commissioner Califf and Minister Oh Yu-Kyoung that took place in March this year.

Building on the inking of this Memorandum of Cooperation, the two organisations will go ahead and hold combined workshops so as to share their experiences in utilising artificial intelligence when it comes to the development of medical products with regulators across the world and pitch in how regulators can aid in the advancement of the usage of innovative technologies so as to bring out a secure and effective medical product.

Latest stories

Related stories

CMS in US Launches WISeR Model to Enhance Original Medicare

The Centers for Medicare & Medicaid Services (CMS) is...

England GP IT Market Witnesses Shake-Up Unseen in 25 Years

England’s National Health Service, which is popularly known as...

Label Expansion In Alzheimers Gives GE HealthCare An Edge

The US Food and Drug Administration (FDA) has gone...

US Health Systems Accelerating AI Collaborations

US Health systems are speeding up their collaborations with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back